Sartorius Stedim Biotech SA (SRTOY)
23.29
-0.99
(-4.08%)
USD |
OTCM |
Oct 08, 16:00
Sartorius Stedim Biotech Shareholders Equity (Quarterly) : 4.844B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.844B |
| March 31, 2026 | 4.734B |
| December 31, 2025 | 4.804B |
| September 30, 2025 | 4.743B |
| June 30, 2025 | 4.700B |
| March 31, 2025 | 4.291B |
| December 31, 2024 | 4.128B |
| September 30, 2024 | 4.355B |
| June 30, 2024 | 4.167B |
| March 31, 2024 | 4.138B |
| December 31, 2023 | 2.915B |
| September 30, 2023 | 2.747B |
| June 30, 2023 | 2.803B |
| March 31, 2023 | 2.630B |
| December 31, 2022 | 2.614B |
| September 30, 2022 | 2.227B |
| June 30, 2022 | 2.145B |
| March 31, 2022 | 2.140B |
| December 31, 2021 | 1.883B |
| September 30, 2021 | 1.933B |
| June 30, 2021 | 1.979B |
| March 31, 2021 | 1.799B |
| December 31, 2020 | 1.760B |
| September 30, 2020 | 1.580B |
| June 30, 2020 | 1.414B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.346B |
| December 31, 2019 | 1.301B |
| September 30, 2019 | 1.273B |
| June 30, 2019 | 1.252B |
| March 31, 2019 | 1.175B |
| December 31, 2018 | 1.185B |
| September 30, 2018 | 1.124B |
| June 30, 2018 | 1.071B |
| March 31, 2018 | 1.116B |
| December 31, 2017 | 1.047B |
| September 30, 2017 | 982.64M |
| June 30, 2017 | 908.79M |
| March 31, 2017 | 857.03M |
| December 31, 2016 | 799.51M |
| September 30, 2016 | 800.26M |
| June 30, 2016 | 745.56M |
| March 31, 2016 | 756.09M |
| December 31, 2015 | 696.80M |
| September 30, 2015 | 693.19M |
| June 30, 2015 | 648.58M |
| March 31, 2015 | 608.85M |
| December 31, 2014 | 644.32M |
| September 30, 2014 | 649.82M |
| June 30, 2014 | 667.87M |
| March 31, 2014 | 680.17M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Lifecore Biomedical, Inc. | 16.09M |
| Sanofi | -- |
| Codexis, Inc. | 32.96M |
| Nicox SA | -- |
| Evotec SE | 760.96M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.052B |
| Total Liabilities (Quarterly) | 4.197B |
| Debt to Equity Ratio | 0.5671 |
| Current Ratio | 1.160 |
| Net Debt Paydown Yield | 0.42% |